Commonwealth Equity Services’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Other funds holding TARA
AA
PFSRSONJ
SCM
GI
EWA
AP
SS
Commonwealth Equity Services's TARA Position: Q2 2026 in Review
Commonwealth Equity Services held its Protara Therapeutics (TARA) position steady in Q2 2026 at 11,000 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #4318.
Commonwealth Equity Services first reported a position in TARA in Q2 2024 and has held it in 8 quarters since. The position peaked at $195K in Q4 2024. 16 funds tracked by Wall St. Rank hold TARA as of Q2 2026.
- Commonwealth Equity Services held 11,000 shares of Protara Therapeutics worth $42K as of Q2 2026.
- Commonwealth Equity Services left its Protara Therapeutics share count unchanged in Q2 2026.
- Protara Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4318 holding.
- Commonwealth Equity Services first reported a position in Protara Therapeutics in Q2 2024 and has held it in 8 quarters since.
- Commonwealth Equity Services's Protara Therapeutics position peaked at $195K in Q4 2024.
- 16 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.